Diphtheria Toxin Antibodies

Santa Cruz Biotechnology features a diverse variety of Diphtheria Toxin monoclonal antibodies for research focused on understanding the mechanisms of diphtheria toxin and its effects on cellular processes. Diphtheria Toxin Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Diphtheria toxin, produced by the bacterium Corynebacterium diphtheriae, is a potent exotoxin that inhibits protein synthesis in eukaryotic cells, leading to cell death. Understanding the function of diphtheria toxin is crucial for developing therapeutic strategies and vaccines against diphtheria, as well as for studying its role in pathogenesis. Diphtheria toxin research has significant implications for public health and disease prevention. Investigating the molecular mechanisms of diphtheria toxin action provides valuable insights into bacterial pathogenesis and host-pathogen interactions. Current research focuses on understanding how diphtheria toxin enters cells and disrupts cellular functions. Exploring the structural components of diphtheria toxin helps reveal potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of diphtheria toxin and developing new therapeutic approaches.